| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.053 | 0.7 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.05 | 0.7 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.052 | 0.7 |
| mRNA | hyperforin | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.1 | 0.8 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |